Stay updated with breaking news from Adams Mostafa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) had its target price lifted by equities researchers at HC Wainwright from $3.00 to $5.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 352.49% from the company’s […]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Research analysts at Brookline Capital Management lowered their Q3 2024 earnings per share (EPS) estimates for X4 Pharmaceuticals in a note issued to investors on Monday, April 29th. Brookline Capital Management analyst L. Cann now expects that the company will post earnings per share of ($0.19) for […]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Equities research analysts at Brookline Capital Management increased their FY2026 earnings estimates for X4 Pharmaceuticals in a research report issued to clients and investors on Monday, April 29th. Brookline Capital Management analyst L. Cann now expects that the company will earn $0.32 per share for the year, […]
HC Wainwright reiterated their buy rating on shares of X4 Pharmaceuticals (NASDAQ:XFOR – Free Report) in a research note released on Friday, Benzinga reports. The brokerage currently has a $3.00 price objective on the stock. Separately, B. Riley lowered X4 Pharmaceuticals from a buy rating to a neutral rating and lowered their target price for […]
HC Wainwright reaffirmed their buy rating on shares of X4 Pharmaceuticals (NASDAQ:XFOR – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $3.00 target price on the stock. Separately, B. Riley downgraded X4 Pharmaceuticals from a buy rating to a neutral rating and reduced their target price for the […]